journal article·2021-01-13Open access

Bifunctional Janus Particles as Multivalent Synthetic Nanoparticle Antibodies (SNAbs) for Selective Depletion of Target Cells

Jiaying Liu, Randall Toy, Casey Vantucci, Pallab Pradhan, Zijian Zhang, Katie M. Kuo, Kelsey P. Kubelick, Da Huo, Jianguo Wen, Jinhwan Kim, Zhiheng Lyu, Simran Dhal, Alexandra Atalis, Shohini K. Ghosh-Choudhary, Emily J. Devereaux, James C. Gumbart, Younan Xia, Stanislav Y. Emelianov, Nick J. Willett, Krishnendu Roy

Nano Letters· Volume 21· Issue 1

Abstract

Monoclonal antibodies (mAb) have had a transformative impact on treating cancers and immune disorders. However, their use is limited by high development time and monetary cost, manufacturing complexities, suboptimal pharmacokinetics, and availability of disease-specific targets. To address some of these challenges, we developed an entirely synthetic, multivalent, Janus nanotherapeutic platform, called Synthetic Nanoparticle Antibodies (SNAbs). SNAbs, with phage-display-identified cell-targeting ligands on one "face" and Fc-mimicking ligands on the opposite "face", were synthesized using a custom, multistep, solid-phase chemistry method. SNAbs efficiently targeted and depleted myeloid-derived immune-suppressor cells (MDSCs) from mouse-tumor and rat-trauma models, ex vivo. Systemic injection of MDSC-targeting SNAbs efficiently depleted circulating MDSCs in a mouse triple-negative breast cancer model, enabling enhanced T cell and Natural Killer cell infiltration into tumors. Our results demonstrate that SNAbs are a versatile and effective functional alternative to mAbs, with advantages of a plug-and-play, cell-free manufacturing process, and high-throughput screening (HTS)-enabled library of potential targeting ligands.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Nanoscale Materials, Argonne National Laboratory, Lemont, Illinois 60517, United States

School of Medicine, University of Pittsburgh, 3550 Terrace St., Pittsburgh, Pennsylvania 15213, United States

Orthopaedics Department, Emory University, Atlanta, Georgia 30322, United States

Research Service, Atlanta VA Medical Center, Decatur, Georgia 30033, United States

Funding

Georgia Institute of Technology · Giglio Breast Cancer Innovation Fund · Children and Athletes Regenerative Medicine Foundation

References (68)

Show source-provided references
1. 10.1056/NEJMoa120069410.1056/NEJMoa1200694 ↗
2. 10.1038/nrc323610.1038/nrc3236 ↗
3. 10.1111/j.1476-5381.2009.00190.x10.1111/j.1476-5381.2009.00190.x ↗
4. 10.1038/jid.2013.52110.1038/jid.2013.521 ↗
5. 10.7150/thno.1171110.7150/thno.11711 ↗
6. 10.3389/fimmu.2017.0128710.3389/fimmu.2017.01287 ↗
7. 10.1016/j.it.2016.01.00410.1016/j.it.2016.01.004 ↗
8. 10.1038/nm.339410.1038/nm.3394 ↗
9. 10.1021/am505510m10.1021/am505510m ↗
10. 10.1021/acs.chemmater.6b0532210.1021/acs.chemmater.6b05322 ↗
11. 10.1016/j.ccr.2020.21346710.1016/j.ccr.2020.213467 ↗
12. 10.1016/j.ijpharm.2019.01.02010.1016/j.ijpharm.2019.01.020 ↗
13. 10.1021/acs.nanolett.7b0382910.1021/acs.nanolett.7b03829 ↗
14. 10.1002/smll.20190496010.1002/smll.201904960 ↗
15. 10.1039/C6AN00325G10.1039/C6AN00325G ↗
16. 10.1039/c2cs35032g10.1039/c2cs35032g ↗
17. 10.1021/am302528g10.1021/am302528g ↗
18. 10.1021/la301007910.1021/la3010079 ↗
19. 10.1371/journal.pone.001592710.1371/journal.pone.0015927 ↗
20. 10.4049/jimmunol.130136510.4049/jimmunol.1301365 ↗
21. 10.1371/journal.pone.012377210.1371/journal.pone.0123772 ↗
22. 10.4049/jimmunol.080274010.4049/jimmunol.0802740 ↗
23. 10.1097/SLA.000000000000178310.1097/SLA.0000000000001783 ↗
24. 10.3389/fimmu.2019.0032710.3389/fimmu.2019.00327 ↗
25. 10.2119/molmed.2010.0017810.2119/molmed.2010.00178 ↗
26. 10.3389/fimmu.2019.0091710.3389/fimmu.2019.00917 ↗
27. 10.4049/jimmunol.090266110.4049/jimmunol.0902661 ↗
28. 10.1186/2051-1426-1-1010.1186/2051-1426-1-10 ↗
29. 10.1128/IAI.00239-1210.1128/IAI.00239-12 ↗
30. 10.1158/0008-5472.CAN-13-154510.1158/0008-5472.CAN-13-1545 ↗
31. 10.1158/0008-5472.CAN-09-369010.1158/0008-5472.CAN-09-3690 ↗
32. 10.1182/blood-2011-07-36582510.1182/blood-2011-07-365825 ↗
33. 10.1002/cam4.18610.1002/cam4.186 ↗
34. 10.1189/jlb.021205910.1189/jlb.0212059 ↗
35. 10.1136/annrheumdis-2016-20978610.1136/annrheumdis-2016-209786 ↗
36. Sukhatme, Vikas P.; Husain, Z. Cancer Therapy Targeting Tetraspanin 33 (Tspan33) in Myeloid Derived Suppressor Cells. WO 2016/210241 Al, 2016.
37. 10.1016/j.clim.2013.08.00510.1016/j.clim.2013.08.005 ↗
38. 10.1038/nm.356010.1038/nm.3560 ↗
39. 10.1038/nrc389310.1038/nrc3893 ↗
40. 10.1038/ncomms1215010.1038/ncomms12150 ↗
41. 10.4049/jimmunol.181.7.466610.4049/jimmunol.181.7.4666 ↗
42. 10.1111/j.1365-2567.2012.03566.x10.1111/j.1365-2567.2012.03566.x ↗
43. 10.1096/fj.08-11706910.1096/fj.08-117069 ↗
44. 10.1021/ja509513c10.1021/ja509513c ↗
45. 10.1021/acs.nanolett.8b0330510.1021/acs.nanolett.8b03305 ↗
46. 10.7150/thno.3254610.7150/thno.32546 ↗
47. 10.1007/s10439-011-0449-410.1007/s10439-011-0449-4 ↗
48. 10.1039/C7TB00150A10.1039/C7TB00150A ↗
49. 10.1142/S179398441341001810.1142/S1793984413410018 ↗
50. 10.1371/journal.pone.006098910.1371/journal.pone.0060989 ↗
51. 10.4049/jimmunol.140230110.4049/jimmunol.1402301 ↗
52. 10.1016/j.injury.2007.08.04110.1016/j.injury.2007.08.041 ↗
53. Cheng L. · Int. J. Clin. Exp. Pathol. · 2017 · 10 · 11063
54. 10.1016/j.biomaterials.2020.12040510.1016/j.biomaterials.2020.120405 ↗
55. 10.1038/nnano.2015.34210.1038/nnano.2015.342 ↗
56. 10.1021/nn507025910.1021/nn5070259 ↗
57. 10.3390/molecules1601085710.3390/molecules16010857 ↗
58. 10.1038/nrd.2016.19910.1038/nrd.2016.199 ↗
59. 10.4161/mabs.2724010.4161/mabs.27240 ↗
60. 10.1073/pnas.110535110810.1073/pnas.1105351108 ↗
61. 10.1038/cgt.2013.8110.1038/cgt.2013.81 ↗
62. 10.1371/journal.pone.004067710.1371/journal.pone.0040677 ↗
63. 10.1073/pnas.141149911110.1073/pnas.1411499111 ↗
64. 10.1111/j.1600-0854.2012.01382.x10.1111/j.1600-0854.2012.01382.x ↗
65. 10.1126/scitranslmed.aaf941810.1126/scitranslmed.aaf9418 ↗
66. 10.1073/pnas.100824810710.1073/pnas.1008248107 ↗
67. 10.1155/2014/59865410.1155/2014/598654 ↗
68. 10.1007/s00018-019-03048-x10.1007/s00018-019-03048-x ↗